Table 1 Fold-difference values for 88 genes in 55 patients with CFS: as a group, and in each of seven CFS subtypes
Gene symbolmRNA accession no.Taqman PCR assay ID‡PCR*Two-tail p value for PCR*Subtype
1234567
ABCD4*NM_020323Hs00245340_m12.080.0282.041.661.464.482.13
ACTR3NM_005721Hs00828586_m11.420.00423.772.441.930.931.860.871.76
AKAP10NM_007202Hs00183673_m11.540.00112.471.961.120.992.272.081.93
ANAPC11*NM_016476Hs00212858_m13.320.000334.332.262.025.573.274.26
ANAPC5NM_016237Hs00212120_m12.360.000163.883.641.693.563.880.83
APP†NM_201413Hs00169098_m12.54.33×10−92.45†3.11†1.73†1.77†3.94†2.87†4.16†
ARL4CNM_005737Hs00255039_s12.968.90×10−63.501.834.613.893.27
ARPC5NM_005717Hs00271722_m13.236.82×10−89.035.545.272.253.591.725.81
ARSDNM_001669Hs00534692_m11.980.0012.302.081.271.852.67
ATP6V1C1NM_001695Hs00184625_m12.030.000293.293.064.741.182.682.471.94
BCORNM_017745Hs00372369_m11.60.00981.431.530.840.953.661.961.74
BMP2KNM_198892Hs00214079_m11.30.0140.771.411.170.991.481.540.85
BRMS1*NM_015399Hs00363036_m12.680.00143.161.001.374.352.57
CD2BP2*NM_006110Hs00272036_m11.85.35×10−62.191.762.371.341.632.783.45
CD47NM_198793Hs00179953_m12.20.000134.373.241.301.243.321.911.62
CEP350NM_014810Hs00402774_m12.020.00483.136.762.281.272.802.031.20
CITED2NM_006079Hs00366696_m12.394.45×10−62.640.752.162.872.23
CMTM6NM_017801Hs00215083_m11.410.0123.842.482.380.841.990.891.63
CREBBPNM_004380Hs00231733_m11.430.0160.931.291.501.212.68
CRKNM_016823Hs00180418_m12.511.11×10−53.654.391.792.313.633.59
CTBP1NM_001328Hs00179922_m11.450.0620.860.941.352.49
CXCR4†NM_003467Hs00607978_s11.677.80×10−51.121.152.18†2.41†
EBI2NM_004951Hs00270639_s13.440.001211.682.911.476.184.894.38
EGR1NM_001955Hs00152928_m12.820.0151.187.710.941.732.012.971.92
EGR3NM_004421Hs00231780_m11.920.0171.141.282.603.461.61
EIF2B4*NM_172195Hs00248984_m12.060.0253.681.551.102.86
EIF3S10NM_003750Hs00186707_m13.580.00291.983.785.642.605.78
EIF4G1*NM_198241Hs00191933_m13.050.00333.258.571.501.833.715.84
EIF4G3NM_003760Hs00186804_m11.671.37×10−53.070.941.482.281.722.03
ETS1NM_005238Hs00901425_m12.111.00×10−52.793.510.981.541.642.002.77
FAM126BNM_173822Hs00545158_m11.640.00344.641.802.230.952.791.351.01
FNTA†NM_002027Hs00357739_m12.183.82×10−64.80†3.32†2.08†1.492.48†2.22†1.49
GABARAPL1*NM_031412Hs00744468_s15.646.10×10−512.4313.978.312.495.024.754.37
GABPANM_002031Hs00745591_s18.063.00×10−46.5923.2815.562.923.369.273.44
GCN1L1NM_006836Hs00412445_m12.050.000522.032.001.541.382.414.263.22
GLTSCR2NM_015710Hs00414236_m11.240.0261.971.851.140.771.301.412.20
GNASNM_080425Hs00255603_m11.71.09×10−72.143.161.731.271.671.461.87
GSN*NM_198252Hs00609276_m12.930.000174.397.073.511.423.792.365.90
GTF2A2NM_004492Hs00362112_m11.790.031.425.571.161.651.90
HIF1ANM_001530Hs00153153_m10.810.0161.241.350.860.591.07
IFNAR1NM_000629Hs00265057_m11.760.000733.903.222.211.051.642.901.54
IL10RA*NM_001558Hs00387004_m11.739.87×10−61.271.540.761.311.312.872.29
IL6RNM_000565Hs00794121_m11.190.065.423.113.322.943.103.034.08
IL6ST†NM_002184Hs00174360_m11.80.0022.87†1.52†0.771.221.85†1.71†5.06†
IL7RNM_002185Hs00233682_m10.820.0321.161.340.980.571.440.660.64
JAK1NM_002227Hs00233820_m11.911.86×10−81.733.191.261.401.942.122.40
KHSRP*NM_003685Hs00269352_m11.670.000261.432.131.251.171.892.492.73
MAPK9NM_139070Hs00177102_m11.40.0451.742.361.082.342.12
METTL3NM_019852Hs00219820_m12.060.00013.942.950.761.381.973.142.11
MRPL23*NM_021134Hs00221699_m12.060.0015.412.100.701.481.983.043.05
MRPS6NM_032476Hs00606808_m11.530.0252.532.591.251.331.620.86
MRRFNM_138777Hs00751845_s18.910.000428.2738.4013.242.855.859.969.11
MSN*NM_002444Hs00792607_mH1.330.00161.562.161.761.031.021.191.87
MTMR6NM_004685Hs00395064_m11.710.00255.072.102.381.232.170.591.89
NFKB1NM_003998Hs00231653_m11.594.04×10−52.261.141.341.602.56
NHLH1NM_005589Hs00271582_s111.517.00×10−43.8747.1920.195.343.9015.625.32
NR1D2NM_005126Hs00233309_m12.440.000763.172.452.661.084.032.00
NTE*NM_006702Hs00198648_m11.70.044.408.110.970.941.551.332.24
NUFIP2NM_020772Hs00325168_m11.50.000362.051.940.741.022.441.971.45
PAPOLANM_032632Hs00413685_m11.320.001941.901.931.410.881.991.031.40
PDCD2*NM_002598Hs00751277_sH6.760.009626.4624.2817.552.843.788.815.38
PDCD6NM_013232Hs00737034_m11.740.000191.991.411.941.472.202.102.62
PEX16*NM_004813Hs00191337_m11.740.00342.582.461.152.082.132.33
PGM2NM_018290Hs00217619_m12.171.68×10−64.353.492.761.283.042.262.41
PIK3R1NM_181523Hs00236128_m10.680.0251.610.500.250.461.33
PKN1*NM_213560Hs00177028_m11.569.40×10−52.302.110.951.141.971.732.60
POLR2G*NM_002696Hs00275738_m12.580.00783.383.042.791.232.568.072.63
PPP2R5CNM_002719Hs00604902_m11.380.0222.591.631.030.952.151.851.14
PRKAA1NM_006251Hs01562315_m11.720.000523.271.981.431.362.231.680.97
PRKAR1ANM_002734Hs00267597_m12.632.91×10−84.815.674.731.642.691.544.06
PUM2NM_015317Hs00209677_m11.390.000641.351.321.291.361.81
RAP2CNM_021183Hs00221801_m12.10.0154.972.071.112.243.090.53
REPIN1NM_013400Hs00274221_s13.626.00×10−63.867.292.661.671.934.762.19
RNF141NM_16422Hs00212656_m12.371.62×10−63.792.863.161.853.562.261.02
SELENBP1NM_003944Hs00187625_m11.920.0023.871.861.282.482.31
SFXN1NM_022754Hs00224259_m11.60.0224.861.891.571.213.500.961.41
SHPRHNM_173082Hs00542737_m11.770.050.922.850.982.211.711.23
SNAP23NM_003825Hs00187075_m12.020.000185.601.823.111.323.372.021.99
SORL1NM_003105Hs00268342_m11.544.10×10−81.311.891.481.261.511.743.09
SOS1NM_005633Hs00362308_m12.310.0024.492.691.281.343.913.371.46
TAF11NM_005643Hs00194573_m11.870.052.324.970.861.232.711.932.60
TCF3NM_003200Hs00413032_m11.440.0231.441.001.342.99
TDP1NM_018319Hs00217832_m11.670.00993.251.351.531.251.802.602.14
TNFRSF1A†NM_001065Hs00533560_m11.370.0162.04†1.131.320.721.481.46
UBTFNM_014233Hs00610729_g12.260.0246.232.231.291.094.27
USP38NM_032557Hs00261419_m11.710.00214.072.080.961.102.032.052.07
WAPALNM_015045Hs00386162_m11.690.0273.273.643.351.072.001.160.91
WDR26NM_025160Hs00228535_m12.620.000125.626.112.841.802.331.203.19
  • For each subtype, genes with fold-difference values of ⩾1.5 up- or downregulated, as compared with normals, were noted and used in further analysis. Genes without values for the subtypes are those for which there was missing data for one or more subtypes.

  • *Kerr et al (2008).6

  • †Genes targeted by existing drugs, and those chronic fatigue syndrome subtypes in which there may be a rationale for a trial of a particular drug (see Results).

  • ‡Assays were pre-designed by Applied Biosystems.